Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults, Circulation, vol.92, pp.785-794, 1995. ,
Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease, Circulation, vol.126, pp.1640-1644, 2012. ,
Asymmetrical hypertrophy of the heart in young adults, Br Heart J, vol.20, pp.1-8, 1958. ,
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy, JAMA, vol.298, pp.405-417, 2007. ,
Hypertrophic Cardiomyopathy Outcomes (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD), Eur Heart J, vol.35, pp.2010-2030 ,
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy, Heart, vol.99, pp.534-575, 2013. ,
Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy, Circulation, vol.121, pp.445-56, 2010. ,
Risk stratification and outcome of patients with hypertrophic cardiomyopathy ³ 60 years of age, Circulation, vol.127, pp.585-93, 2013. ,
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.46, pp.470-476, 2005. ,
Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy, Circulation, vol.116, pp.196-206, 2007. ,
Myths about surgical myectomy: rumors of its death have been greatly exaggerated, Am J Cardiol, vol.101, pp.887-896, 2008. ,
The case for surgery in obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.44, pp.2044-53, 2004. ,
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry, J Am Coll Cardiol, vol.58, pp.2322-2330, 2011. ,
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy, Eur Heart J, vol.33, pp.2080-2087, 2012. ,
) Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy, Circulation, vol.114, pp.216-241, 2006. ,
Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy, Circ Heart Fail, vol.3, pp.574-583, 2010. ,
Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy, J Cardiovasc Electrophysiol, vol.18, pp.483-490, 2007. ,
Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression, Europace, vol.12, pp.347-55, 2010. ,
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy, Circulation, vol.130, pp.484-95, 2014. ,
Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy, Eur Heart J Cardiovasc Imaging, vol.17, pp.613-634, 2016. ,
Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy, Eur Heart J Cardiovasc Imaging, vol.13, pp.617-640, 2012. ,
Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy, Circulation, vol.109, issue.8, pp.984-989, 2004. ,
Characteristics of Left Atrial Deformation Parameters and Their Prognostic Impact in Patients with Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking Echocardiography, Echocardiography, vol.32, pp.1821-1851, 2015. ,
The Remarkable 50 Years of Imaging in HCM and How it Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR, JACC Cardiovasc Imaging, vol.9, pp.858-872, 2016. ,
, Rev Esp Cardiol, vol.62, pp.48-56, 2009.
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients, J Am Coll Cardiol, vol.36, pp.2212-2220, 2000. ,
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy, JAMA, vol.298, pp.405-417, 2007. ,
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies, J Am Coll Cardiol, vol.65, pp.1915-1943, 2015. ,
Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.41, pp.315-336, 2003. ,
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients, J Am Coll Cardiol, vol.42, pp.873-882, 2003. ,
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy, N Engl J Med, vol.348, pp.295-303, 2003. ,
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.45, pp.697-704, 2005. ,
Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy, Eur Heart J, vol.30, pp.2599-605, 2009. ,
Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy, Am J Cardiol, vol.104, pp.695-704, 2009. ,
Predictors of sudden cardiac death in hypertrophic cardiomyopathy, Am J Cardiol, vol.82, pp.774-782, 1998. ,
Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy, Eur Heart J, vol.27, p.3073, 2006. ,
Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy, Eur Heart J, vol.27, pp.1311-1319, 2006. ,
Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration, J Am Coll Cardiol, vol.41, pp.987-93, 2003. ,
Syncope and risk of sudden death in hypertrophic cardiomyopathy, Circulation, vol.119, pp.1703-1713, 2009. ,
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, vol.16, pp.233-70, 2015. ,
Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy, N Engl J Med, vol.342, pp.1778-85, 2000. ,
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy, Lancet, vol.357, pp.420-424, 2001. ,
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms, J Am Coll Cardiol, vol.45, pp.1076-80, 2005. ,
Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.11, pp.752-758, 1988. ,
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy, Circulation, vol.107, pp.2872-2877, 2003. ,
Recommendations for the evaluation of left ventricular diastolic function by echocardiography, J Am Soc Echocardiogr, vol.22, pp.107-140, 2009. ,
Zamorano & I. Scientific Document Committee of the European Association of Cardiovascular (2013) Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, vol.14, pp.611-655 ,
AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, C. American College of, A. American College of Cardiology/American Heart & A. American Heart, vol.148, pp.1-132, 2014. ,
Feasibility and reference values of left atrial longitudinal strain imaging by two-dimensional speckle tracking, Cardiovasc Ultrasound, vol.7, p.6, 2009. ,
Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction, Eur Heart J Cardiovasc Imaging, vol.16, pp.62-69, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02282410
New echocardiographic techniques for evaluation of left atrial mechanics, Eur Heart J Cardiovasc Imaging, vol.13, pp.973-84, 2012. ,
Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy, Am J Cardiol, vol.116, pp.757-64, 2015. ,
ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur Heart J, vol.35, pp.2733-79, 2014. ,
Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors, Am J Cardiol, vol.113, pp.1550-1555, 2014. ,
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance, J Am Coll Cardiol, vol.41, pp.1561-1568, 2003. ,
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance, Circulation, vol.108, pp.54-63, 2003. ,
Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?, J Am Coll Cardiol, vol.41, pp.1568-72, 2003. ,
Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.56, pp.875-87, 2010. ,
Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy, Am J Cardiol, vol.106, pp.261-268, 2010. ,
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy, Circ Heart Fail, vol.3, pp.51-59, 2010. ,
Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy, Am J Cardiol, vol.113, pp.1234-1243, 2014. ,
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance, J Am Coll Cardiol, vol.51, pp.1369-74, 2008. ,
Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy, Circ Heart Fail, vol.1, pp.184-91, 2008. ,
Prognostic Value of LGE-CMR in HCM: A Meta-Analysis, JACC Cardiovasc Imaging, vol.9, pp.1392-1402, 2016. ,
Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy, Circ Cardiovasc Imaging, p.10, 2017. ,
Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy, Eur J Med Res, vol.21, p.21, 2016. ,
Left atrial dysfunction as a correlate of heart failure symptoms in hypertrophic cardiomyopathy, J Am Soc Echocardiogr, vol.23, pp.1090-1098, 2010. ,
An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography, Int J Cardiovasc Imaging, vol.24, pp.45-52, 2008. ,
Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation, Circ Arrhythm Electrophysiol, p.10, 2017. ,
Importance of left atrial function in patients with myocardial infarction, Circulation, vol.67, pp.566-71, 1983. ,
Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications, Am Heart J, vol.156, pp.1056-64, 2008. ,
Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy, Am Heart J, vol.149, pp.730-736, 2005. ,
Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy, J Am Soc Echocardiogr, vol.22, pp.76-81, 2009. ,
Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy), Am J Cardiol, vol.98, pp.960-965, 2006. ,
Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy, J Am Soc Echocardiogr, vol.22, pp.1338-1381, 2009. ,
Imaging (2016) Two-dimensional speckle tracking echocardiography: standardization efforts based on synthetic ultrasound data, Eur Heart J Cardiovasc Imaging, vol.17, pp.693-701 ,
Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better? Circ Cardiovasc Imaging, p.10, 2017. ,